All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Cancer

Human Genetics   Research Article

Value of diffusion weighted imaging in the differential diagnosis of benign and malignant breast lesions at 3.0T MRI

Authors: X.Y. Jiang, Q.Z. Xie, X.S. Cao, T. Gao, C.Y. Xing and X.L. Li

The aim of this study was to investigate the correlation between apparent diffusion coefficients (ADCs), the relative apparent diffusion coefficient (rADC), and the pathological prognostic factor human epidermal growth factor receptor 2 (HER-2) in patients with breast cancer. A total of 64 women with breast cancer underwent br.. Read More»

Genet. Mol. Res. 13(3):
2014.September.26.15
DOI:
10.4238/2014.September.26.15
Human Genetics   Research Article

Overregulation of microRNA-212 in the poor prognosis of esophageal cancer patients

Authors: B. Qi, S.G. Liu, X.G. Qin, W.J. Yao, J.G. Lu, L. Guo, T.Y. Wang, H.C. Li and B.S. Zhao

There have been few reports evaluating the expression and function of the microRNA miR-212 in esophageal cancer. The aim of this study was to investigate the relationship between miR-212 expression and clinicopathological factors and prognoses of esophageal cancer. MicroRNA was extracted from 46 esophageal cancer patients usin.. Read More»

Genet. Mol. Res. 13(3):
2014.September.26.18
DOI:
10.4238/2014.September.26.18
Human Genetics   Research Article

Relationship between genetic polymorphisms of DNA ligase 1 and non-small cell lung cancer susceptibility and radiosensitivity

Authors: H. Tian, X. He, L. Yin, W.J. Guo, Y.Y. Xia and Z.X. Jiang

The aim of this study was to examine the relationship between genetic polymorphisms in DNA ligase 1 (LIG1) and nonsmall cell lung cancer (NSCLC) susceptibility and radiosensitivity in a Chinese population. This was a case-control study that included 352 NSCLC patients and 448 healthy controls. Polymerase chain reactionrestriction fragment length polymorph.. Read More»

Genet. Mol. Res. 14(2):
2015.June.26.14
DOI:
10.4238/2015.June.26.14
Human Genetics   Research Article

Tristetraprolin: a novel mediator of the anticancer properties of resveratrol

Authors: C. Li, C. Tang and G. He

Resveratrol is a natural compound that exhibits anticancer properties. Previous studies have proved that it can inhibit the proliferation of breast cancer cell lines and upregulate some cytokines such as cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF). The initiation and progression of cancer are associa.. Read More»

Genet. Mol. Res. 15(2):
gmr.15027213
DOI:
10.4238/gmr.15027213
Human Genetics   Research Article

Association of CYP1A1 MspI polymorphism with oral cancer risk in Asian populations: a meta-analysis

Authors: J.L. Xu, R. Xia, L. Sun, X. Min, Z.H. Sun, C. Liu, H. Zhang and Y.M. Zhu

Numerous studies regarding the association between the CYP1A1 MspI polymorphism and oral cancer risk in Asian populations have shown controversial results. To get a more precise estimation of this relationship, we conducted a comprehensive meta-analysis. PubMed, the Cochrane Library, Elsevier Science Direct, Web of Knowledge, .. Read More»

Genet. Mol. Res. 15(2):
gmr.15027688
DOI:
10.4238/gmr.15027688
Human Genetics   Research Article

Decreased miR-452 expression in human colorectal cancer and its tumor suppressive function

Authors: T. Tang, G.C. Zhang, C.F. Li, Y.F. Liu and W.Y. Wang

 -.. Read More»

Genet. Mol. Res. 15(2):
gmr.15027730
DOI:
10.4238/gmr.15027730
Human Genetics   Research Article

HNF1b is involved in prostate cancer risk via modulating androgenic hormone effects and coordination with other genes

Authors: Y.L. Hu, D. Zhong, F. Pang, Q.Y. Ning, Y.Y. Zhang, G. Li, J.Z. Wu and Z.N. Mo

Prostate cancer is one of the most commonly diagnosed male malignancies. Genome wide association studies have revealed HNF1b to be a major risk gene for prostate cancer susceptibility. We examined the mechanisms of involvement of HNF1b in prostate cancer development. We integrated data from Gene Expression Omnibus prostate cancer genes from the Dragon Dat.. Read More»

Genet. Mol. Res. 12(2):
2013.April.25.4
DOI:
10.4238/2013.April.25.4
Human Genetics   Research Article

ERCC1 C118T polymorphism has predictive value for platinum-based chemotherapy in patients with late-stage bladder cancer

Authors: Z.C. Xu, H.Z. Cai, X. Li, W.Z. Xu, T. Xu, B. Yu, Q. Zou and L. Xu

This study aims to investigate the association between ERCC1 codon C118T polymorphism and the response rate of platinum-based chemotherapy in patients with late-stage bladder cancer. A total of 41 eligible patients histologically confirmed as having stage IV muscle-invasive transitional cell carcinoma of the bladder were treat.. Read More»

Genet. Mol. Res. 15(2):
gmr.15027801
DOI:
10.4238/gmr.15027801
Human Genetics   Research Article

Clinical significance of CTHRC1 protein expression in human cancers: a meta-analysis

Authors: S.F. Wang, Z. Yin, J.J. Yin, W. Zhang and C.G. Dong

The aim of this meta-analysis was to investigate the overall diagnostic and prognostic values of CTHRC1 expression in human cancer development. Based on the inclusion and exclusion criteria, 8 cohort studies were included in the meta-analysis. The data were extracted, and analyses were performed using a random-effects model. S.. Read More»

Genet. Mol. Res. 15(2):
gmr.15027855
DOI:
10.4238/gmr.15027855
Human Genetics   Research Article

Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis

Authors: M. Zhang, L.J. Zhao, W.Q. Liang and Z.P. Mao

Head and neck cancer (HNC) is one of the most prevalent cancers; it is often diagnosed at its advanced stage and has a low 5-year survival rate. Evidence suggests that noninvasive biomarker microRNAs (miRNAs) are valuable for early diagnosis of HNC. This meta-analysis assessed the diagnostic value of miRNAs in HNC detection. A systematic literature search.. Read More»

Genet. Mol. Res. 14(4):
2015.December.11.3
DOI:
10.4238/2015.December.11.3